These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2862613)

  • 21. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.
    Nemeroff CB; Youngblood WW; Manberg PJ; Prange AJ; Kizer JS
    Science; 1983 Sep; 221(4614):972-5. PubMed ID: 6136092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
    Ellison DW; Beal MF; Mazurek MF; Malloy JR; Bird ED; Martin JB
    Brain; 1987 Dec; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum.
    Foster AC; Whetsell WO; Bird ED; Schwarcz R
    Brain Res; 1985 Jun; 336(2):207-14. PubMed ID: 3159462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex.
    Storey E; Kowall NW; Finn SF; Mazurek MF; Beal MF
    Ann Neurol; 1992 Oct; 32(4):526-34. PubMed ID: 1280937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal deficiency of L-pyroglutamic acid in Huntington's disease is accompanied by increased plasma levels.
    Uhlhaas S; Lange H
    Brain Res; 1988 Aug; 457(1):196-9. PubMed ID: 2971422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin content in the basal ganglia in Huntington's disease. The expression of cholecystokinin immunoreactivity in striatal grafts to ibotenic acid-lesioned rat striatum.
    Emson PC; Dawbarn D; Rossor MN; Rehfeld JF; Brundin P; Isacson O; Björklund A
    Ann N Y Acad Sci; 1985; 448():488-94. PubMed ID: 3161446
    [No Abstract]   [Full Text] [Related]  

  • 27. Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: studies in postmortem tissues and in rats with kainic acid lesions.
    Melamed E; Hefti F; Bird ED
    Neurology; 1982 Jun; 32(6):640-4. PubMed ID: 6211637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex.
    Mazurek MF; Beal MF
    Neurology; 1991 May; 41(5):716-9. PubMed ID: 1674117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Huntington's disease: changes in tachykinin content in postmortem brains.
    Arai H; Emson PC; Carrasco LH
    Ann Neurol; 1987 Nov; 22(5):587-94. PubMed ID: 2447825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia.
    Schoemaker H; Morelli M; Deshmukh P; Yamamura HI
    Brain Res; 1982 Sep; 248(2):396-401. PubMed ID: 6291702
    [No Abstract]   [Full Text] [Related]  

  • 31. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunohistochemical study of pro-somatostatin-derived peptides in the human brain.
    Bouras C; Magistretti PJ; Morrison JH; Constantinidis J
    Neuroscience; 1987 Sep; 22(3):781-800. PubMed ID: 2891078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins.
    Brown MR; Rivier C; Vale W
    Endocrinology; 1984 May; 114(5):1546-9. PubMed ID: 6143656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications.
    Bartzokis G; Lu PH; Tishler TA; Fong SM; Oluwadara B; Finn JP; Huang D; Bordelon Y; Mintz J; Perlman S
    Neurochem Res; 2007 Oct; 32(10):1655-64. PubMed ID: 17484051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seven peptides derived from pro-somatostatin in rat brain.
    Benoit R; Ling N; Alford B; Guillemin R
    Biochem Biophys Res Commun; 1982 Aug; 107(3):944-50. PubMed ID: 6127997
    [No Abstract]   [Full Text] [Related]  

  • 36. Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease.
    Heyes MP; Swartz KJ; Markey SP; Beal MF
    Neurosci Lett; 1991 Jan; 122(2):265-9. PubMed ID: 1827518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated brain iron is independent from atrophy in Huntington's Disease.
    Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
    Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea.
    Hiley CR; Bird ED
    Brain Res; 1974 Nov; 80(2):355-8. PubMed ID: 4278580
    [No Abstract]   [Full Text] [Related]  

  • 39. Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease.
    Meade CA; Figueredo-Cardenas G; Fusco F; Nowak TS; Pulsinelli WA; Reiner A
    Exp Neurol; 2000 Dec; 166(2):307-23. PubMed ID: 11085896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
    Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
    Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.